British Medical Bulletin 61:1-12 (2002)
© 2002 Oxford University Press
Pulmonary defences to acute respiratory infection
National Heart and Lung Institute at St Mary's Hospital, Imperial College School of Medicine, London, UK
Of all sites in the body, the lung is perhaps challenged by the greatest onslaught of microbial pathogens, many of which would cause lethal infections if unopposed. The immune response to respiratory infection must, therefore, be rapid and efficient. However, the respiratory tract is a fragile tissue with architecture that is finely designed for gas exchange, so that the price of excessive or inappropriate inflammatory responses may itself be very high. The first line of defence comes from barriers such as mucus and cilia, followed by a battery of mediators that constitute the innate response. These include lactoferrin, lysozyme, collectins and defensins. Activation of these molecules can lead directly to lysis of pathogens, or to destruction through opsonisation or the recruitment of inflammatory cells. The adaptive immune response includes the production of neutralising antibodies and the responses of T lymphocytes. Different populations of T lymphocytes may dramatically alter the balance between clearance of the pathogen and induction of tissue damage depending on the cytokines they secrete.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Spinelli Oliveira, J. T. Hancock, M. Hermes-Lima, D. A. Isola, M. Ochs, J. Yu, and D. Wilhem Filho Implications of dealing with airborne substances and reactive oxygen species: what mammalian lungs, animals, and plants have to say? Integr. Comp. Biol., October 1, 2007; 47(4): 578 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vaschetto, J. Grinstein, L. Del Sorbo, A. A. Khine, S. Voglis, E. Tullis, A. S. Slutsky, and H. Zhang Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes J. Leukoc. Biol., April 1, 2007; 81(4): 1022 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Mayer, M. Muehmer, J. Mages, K. Gueinzius, C. Hess, K. Heeg, R. Bals, R. Lang, and A. H. Dalpke Differential Recognition of TLR-Dependent Microbial Ligands in Human Bronchial Epithelial Cells J. Immunol., March 1, 2007; 178(5): 3134 - 3142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Thorley, P. A. Ford, M. A. Giembycz, P. Goldstraw, A. Young, and T. D. Tetley Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages J. Immunol., January 1, 2007; 178(1): 463 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Baussano, I. Tardivo, R. Bellezza-Fontana, M. P. Forneris, A. Lezo, L. Anfossi, M. Castello, V. Aleksandar, and E. Bignamini Neonatal Screening for Cystic Fibrosis Does Not Affect Time to First Infection With Pseudomonas aeruginosa Pediatrics, September 1, 2006; 118(3): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chignard and D. Pidard Neutrophil and Pathogen Proteinases versus Proteinase-Activated Receptor-2 Lung Epithelial Cells: More Terminators than Activators. Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 394 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Valliere, G. Abate, A. Blazevic, R. M. Heuertz, and D. F. Hoft Enhancement of Innate and Cell-Mediated Immunity by Antimycobacterial Antibodies Infect. Immun., October 1, 2005; 73(10): 6711 - 6720. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Mason, R. S. Munson Jr., and L. O. Bakaletz A Mutation in the sap Operon Attenuates Survival of Nontypeable Haemophilus influenzae in a Chinchilla Model of Otitis Media Infect. Immun., January 1, 2005; 73(1): 599 - 608. [Abstract] [Full Text] [PDF] |
||||





